Buy Compounded Tirzepatide for Less at IsraelPharm
A crisis struck in 2023 and persisted well into the first few months of 2024. Patients relying on vital medications for diabetes faced a frightening reality: pharmacies, including ours, had to turn away their orders due to shortages. Earlier this year, we published an article detailing the causes of the shortages, titled “Why is it […]
What You Need to Know About Wegovy for Weight Loss
Wegovy and Zepbound, the latest forms of GLP-1 receptor agonist weight-loss medications, have generated a flood of media and public attention thanks to the effectiveness of weight management, which promotes rapid and sustainable weight and waistline reductions. Since we added them to our range of medications, we have received a lot of positive feedback from […]
April 2024 Pharma News
It seems that evolution in healthcare puts a lie to the famous French saying, “Plus ça change, plus c’est la même chose,” which roughly translates as “the more things change, the more they stay the same.” Maybe that’s appropriate for human behavior, but when it comes to changes in the quality and scope of medicines […]
Medicare now approves weight-loss drugs for people with heart problems
There has been much attention in the media to an announcement from Medicare in mid-March 2024. In essence, it said that it has now agreed to start paying for one of the leading weight-loss drugs for people with heart problems when it is prescribed to treat overweight or obese patients if they are at risk […]
World Obesity Week 2024
As we have highlighted previously, World Obesity Week used to be scheduled in November each year. This year, by consensus of the many governmental and international bodies engaged in public health promotion, it has been moved to March, with the start of Obesity Care Week, which runs from the 4th to the 8th of March. […]
What’s the difference between Ozempic and Mounjaro?
Ozempic / Wegovy and Mounjaro / Zepbound (and their base components semaglutide and tirzepatide) are currently the “hottest” medications on the market. You don’t have to be a doctor or pharmacist to get to this conclusion; the stock market tells the story. Sales of Ozempic / Wegovy (based on semaglutide) from Novo Nordisk and Mounjaro / […]
What We Know About the Obesity Epidemic
Over the last 50 years, global obesity rates have reached such alarming levels that words like “obesity epidemic” and even “pandemic” are being used by respected journals and international bodies like the World Health Organization (WHO) as they try to raise awareness in the public and healthcare sectors. According to the World Health Organization, there […]
Expert opinion: Considering Ozempic for weight loss isn’t reckless
In my role as the senior pharmacist here at IsraelPharm, I ensure that we always provide information and respond to questions with evidence-based answers, backed by personal experience and knowledge. Unfortunately, when the internet (namely social media) is our main source of input, we are often confronted with opinions and feedback that contradict medical facts. […]
Treatments for inherited high cholesterol (Familial Hypercholesterolemia)
As people become more aware of the potentially harmful effects of high-fat food and high cholesterol levels on their health, there is a general feeling that it’s all to do with self-control and willpower and that anyone diagnosed with elevated cholesterol must be doing something wrong that they should fix. However, some people are born […]
If it brings such great benefits, why do people stop taking Ozempic?
A natural question has arisen. “If they have such great benefits and are so popular, why do people stop taking Ozempic, Mounjaro and Wegovy?” Ozempic and Mounjaro are considered “wonder drugs” out of all the treatments for type 2 diabetes, which have brought significant benefits to millions of people worldwide who develop type 2 diabetes and caused […]
